Plasma lipid profile: a predictive marker of disease severity among COVID-19 patients-an opportunity for low-income countries.

Yasser O MosaadMohamed A BarakaAhmed E Abou WardaHayam AteyyaMohammed A HusseinSayed Gaber

Published in: Drugs & therapy perspectives : for rational drug selection and use (2022)

A routine lipid profile test might help as a marker of inflammation and risk stratification in patients with COVID-19. Especially in middle- or low-income countries, the test can rapidly help clinicians to delineate prognostic measures and hence management and treatment plans for this disease as the levels of the lipid profile were correlated with the patients' BMI and infection severity.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
body mass index
peritoneal dialysis
health insurance
patient reported outcomes
replacement therapy